Physician profile
Lauren Richards
NPI 1508250531
$19,692.68
in general payments reported to CMS, 2019-2025
33 companies · $1,271 in 2025
The $1,271 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,089 · 2020: $933 · 2021: $982 · 2022: $5,008 · 2023: $2,188 · 2024: $8,222 · 2025: $1,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,998 · Consulting Fee: $5,600 · Education: $83.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,997.75 |
| Consulting Fee | $5,600.00 |
| Education | $83.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acist Medical Systems, INC. | $7,137.12 | 2022-2025 | |
| Boston Scientific Corporation | $3,734.74 | 2020-2025 | General - Balloon Catheters, Cds - Mct/Cem Monitoring |
| Abbott Laboratories | $2,117.71 | 2020-2025 | Cardiomems, Dragonfly Opstar, Coroflow |
| Medtronic, INC. | $744.85 | 2022-2024 | Micra, Valiant Captivia |
| Janssen Pharmaceuticals, INC | $691.03 | 2019-2024 | Xarelto |
| Amgen INC. | $627.03 | 2024-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $584.93 | 2019-2025 | Lifevest |
| Abiomed | $374.35 | 2022-2024 | Impella |
| Shockwave Medical, INC | $329.19 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cardiovascular Systems INC. | $321.94 | 2019-2022 | |
| Philips North America LLC | $315.40 | 2021-2023 | |
| Astellas Pharma US INC | $297.99 | 2019-2020 | |
| Medtronic Vascular, INC. | $289.42 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $284.41 | 2023-2024 | Farxiga, Wainua |
| Kestra Medical Technology Services, INC. | $255.91 | 2025 | Assure Wcd |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $203.79 | 2024-2025 | Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.50 | 2023-2025 | Jardiance |
| W. L. Gore & Associates, INC. | $175.25 | 2022 | |
| Medical Device Business Services, INC. | $145.43 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2019 | |
| Horizon Therapeutics Plc | $124.96 | 2023 | Krystexxa |
| Veryan Medical Incorporated | $111.52 | 2023 | Biomimics 3d Vascular Stent System |
| Actelion Pharmaceuticals US, INC. | $85.15 | 2023-2024 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $84.27 | 2024 | |
| Chiesi USA, INC. | $83.64 | 2023 | Kengreal |
| Pfizer INC. | $78.06 | 2024-2025 | |
| Atricure, INC. | $42.57 | 2023 | |
| Irhythm Technologies, INC. | $34.29 | 2024 | Zio Xt Patch, Zio Monitor |
| Alnylam Pharmaceuticals INC. | $33.93 | 2024 | Amvuttra |
| Kiniksa Pharmaceuticals, Ltd. | $19.69 | 2023 | Arcalyst |
| Impulse Dynamics (USA) INC. | $17.95 | 2024 | Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $15.47 | 2024 | Arcalyst |
| Eisai INC. | $15.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Richards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.